Development of immune-specific interaction potentials and their application in the multi-agent-system vaccimm

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Woelke, Anna Lena ^a   von Eichborn, Joachim ^a   Murgueitio, Manuela S ^a   Worth, Catherine L ^a   Castiglione, Filippo ^b   Preissner, Robert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE VACCINE; T LYMPHOCYTE RECEPTOR; CANCER VACCINE; HISTOCOMPATIBILITY ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; SUBUNIT VACCINE; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; AREA UNDER THE CURVE; ARTICLE; CANCER IMMUNOTHERAPY; CELL POPULATION; COMPUTER MODEL; CRYSTAL STRUCTURE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; INNATE IMMUNITY; LIGAND BINDING; PREDICTION; RECEPTOR BINDING; SIMULATOR; SOLID TUMOR; TUMOR IMMUNITY; ACTIVE IMMUNIZATION; ALGORITHM; BIOLOGICAL MODEL; COMPUTER SIMULATION; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; NEOPLASM; PROTEIN BINDING; T LYMPHOCYTE;

ALGORITHMS; AMINO ACID SEQUENCE; ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; CANCER VACCINES; COMPUTER SIMULATION; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNOTHERAPY, ACTIVE; MODELS, IMMUNOLOGICAL; NEOPLASMS; PROTEIN BINDING; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; VACCINES, SUBUNIT;

EID: 80051779239     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023257     Document Type: Article

References (35)

1. Palucka K, Ueno H, Banchereau J, (2011) Recent developments in cancer vaccines. J Immunol 186: 1325-1331.
2. Woelke AL, Murgueitio MS, Preissner R, (2010) Theoretical modeling techniques and their impact on tumor immunology. Clin Dev Immunol 2010: 271794.
3. Castiglione F, Toschi F, Bernaschi M, Succi S, Benedetti R, et al. (2005) Computational modeling of the immune response to tumor antigens. J Theor Biol 237: 390-400.
4. Rapin N, Lund O, Bernaschi M, Castiglione F, (2010) Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One 5: e9862.
5. Celada F, Seiden PE, (1992) A computer model of cellular interactions in the immune system. Immunol Today 13: 56-62.
6. Farmer JD, Packard NH, Perelson AS, (1986) The immune system, adaptation, and machine learning. Physica D: Nonlinear Phenomena 22: 187-204.
7. Folcik VA, An GC, Orosz CG, (2007) The Basic Immune Simulator: an agent-based model to study the interactions between innate and adaptive immunity. Theor Biol Med Model 4: 39.
8. Folcik VA, Broderick G, Mohan S, Block B, Ekbote C, et al. (2010) Using an agent-based model to analyze the dynamic communication network of the immune response. Theor Biol Med Model 8: 1.
9. Meier-Schellersheim M, Mack G, (1999) SIMMUNE, a tool for simulating and analyzing immune system behavior. Available:http://wwwcitebaseorg/abstract?id=oai:arXivorg:cs/9903017.
10. Kalita JK, Chandrashekar K, Hans R, Selvam P, (2006) Computational modelling and simulation of the immune system. Int J Bioinform Res Appl 2: 63-88.
11. Mallet DG, De Pillis LG, (2006) A cellular automata model of tumor-immune system interactions. J Theor Biol 239: 334-350.
12. Castiglione F, Duca K, Jarrah A, Laubenbacher R, Hochberg D, et al. (2007) Simulating Epstein-Barr virus infection with C-ImmSim. Bioinformatics 23: 1371-1377.
13. Santoni D, Pedicini M, Castiglione F, (2008) Implementation of a regulatory gene network to simulate the TH1/2 differentiation in an agent-based model of hypersensitivity reactions. Bioinformatics 24: 1374-1380.
14. Baldazzi V, Castiglione F, Bernaschi M, (2006) An enhanced agent based model of the immune system response. Cell Immunol 244: 77-79.
15. Lollini PL, Motta S, Pappalardo F, (2006) Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator. BMC Bioinformatics 7: 352.
16. Pennisi M, Pappalardo F, Palladini A, Nicoletti G, Nanni P, et al. (2010) Modeling the competition between lung metastases and the immune system using agents. BMC Bioinformatics 11 (Suppl 7): S13.
17. Miyazawa S, Jernigan RL, (1999) An empirical energy potential with a reference state for protein fold and sequence recognition. Proteins 36: 357-369.
18. van der Merwe PA, Dushek O, (2011) Mechanisms for T cell receptor triggering. Nat Rev Immunol 11: 47-55.
19. Tolar P, Sohn HW, Liu W, Pierce SK, (2009) The molecular assembly and organization of signaling active B-cell receptor oligomers. Immunol Rev 232: 34-41.
20. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235-242.
21. von Eichborn J, Gunther S, Preissner R, (2010) Structural features and evolution of protein-protein interactions. Genome Inform 22: 1-10.
22. Pichichero ME, (2008) Improving vaccine delivery using novel adjuvant systems. Hum Vaccin 4: 262-270.
23. Siebert JC, Walker EB, (2010) Monitoring cytokine profiles during immunotherapy. Immunotherapy 2: 799-816.
24. Meulmeester E, Ten Dijke P, (2011) The dynamic roles of TGF-beta in cancer. J Pathol 223: 205-218.
25. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D, (2010) Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 50: 1-14.
26. Sakaguchi S, (2011) Regulatory T cells: history and perspective. Methods Mol Biol 707: 3-17.
27. Klebanoff CA, Acquavella N, Yu Z, Restifo NP, (2011) Therapeutic cancer vaccines: are we there yet? Immunol Rev 239: 27-44.
28. Miller AM, Pisa P, (2007) Tumor escape mechanisms in prostate cancer. Cancer Immunol Immunother 56: 81-87.
29. Appella E, Padlan EA, Hunt DF, (1995) Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules. Exs 73: 105-119.
30. Bui HH, Sidney J, Peters B, Sathiamurthy M, Sinichi A, et al. (2005) Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 57: 304-314.
31. Jones J, Otu H, Spentzos D, Kolia S, Inan M, et al. (2005) Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 11: 5730-5739.
32. Leinonen R, Diez FG, Binns D, Fleischmann W, Lopez R, et al. (2004) UniProt archive. Bioinformatics 20: 3236-3237.
33. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, et al. (2006) A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 24: 817-819.
34. Nielsen M, Lundegaard C, Lund O, (2007) Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 8: 238.
35. Peters B, Sidney J, Bourne P, Bui HH, Buus S, et al. (2005) The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol 3: e91.